Cigna Group (NYSE:CI) Cut to Outperform at Raymond James Financial

Raymond James Financial lowered shares of Cigna Group (NYSE:CI) from a strong-buy rating to an outperform rating in a research note published on Monday morning, MarketBeat Ratings reports. They currently have $320.00 target price on the health services provider’s stock, down from their previous target price of $350.00.

A number of other analysts have also weighed in on CI. Weiss Ratings restated a “hold (c)” rating on shares of Cigna Group in a research report on Monday, June 1st. The Goldman Sachs Group increased their price objective on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Royal Bank Of Canada lifted their price objective on shares of Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a research note on Friday, May 1st. Sanford C. Bernstein raised their price objective on shares of Cigna Group from $371.00 to $381.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Finally, Morgan Stanley boosted their price objective on Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a report on Wednesday, May 20th. Fifteen investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, Cigna Group has a consensus rating of “Moderate Buy” and a consensus target price of $339.45.

Cigna Group Stock Performance

NYSE:CI opened at $270.53 on Monday. The stock has a fifty day moving average price of $286.09 and a 200-day moving average price of $281.17. The company has a market cap of $71.48 billion, a price-to-earnings ratio of 11.19, a PEG ratio of 0.94 and a beta of 0.29. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.18. The business had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same quarter last year, the business posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities analysts anticipate that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s dividend payout ratio (DPR) is presently 25.82%.

Insider Transactions at Cigna Group

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This represents a 27.52% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares in the company, valued at approximately $10,054,560.34. This represents a 85.46% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Meridian Wealth Management LLC grew its stake in Cigna Group by 1.7% in the 2nd quarter. Meridian Wealth Management LLC now owns 2,955 shares of the health services provider’s stock valued at $815,000 after purchasing an additional 49 shares during the period. Capital Analysts LLC raised its stake in shares of Cigna Group by 27.4% during the 2nd quarter. Capital Analysts LLC now owns 1,014 shares of the health services provider’s stock worth $280,000 after purchasing an additional 218 shares during the period. Colrain Capital LLC raised its stake in shares of Cigna Group by 2.4% during the 2nd quarter. Colrain Capital LLC now owns 48,944 shares of the health services provider’s stock worth $13,493,000 after purchasing an additional 1,127 shares during the period. HighTower Advisors LLC boosted its holdings in shares of Cigna Group by 402.7% in the 2nd quarter. HighTower Advisors LLC now owns 354,398 shares of the health services provider’s stock worth $97,701,000 after buying an additional 283,897 shares during the last quarter. Finally, Alexander Randolph Advisory Inc. boosted its holdings in shares of Cigna Group by 1.3% in the 2nd quarter. Alexander Randolph Advisory Inc. now owns 8,194 shares of the health services provider’s stock worth $2,259,000 after buying an additional 106 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.